Evaluation of Prognostic Monitoring for Young Breast Cancer Patients

Evaluation of Prognostic Monitoring for Young Breast Cancer Patients Via Analysis of Immunoinflammation-related Protein Complexes in Blood

The relationship between immune inflammation-related protein complexes in blood and recurrence or metastasis of breast cancer with completed standard treatment for young ladies will be studied.

200 patients younger than 35 with breast cancer will be followed up. Peripheral venous blood was collected every 3 to 6 months. Change regularity of breast cancer-specific immune inflammation-related protein complexes in blood at different follow-up time points will be studied. The relationship between disease specific protein complexes and pathological state of patients will be analyzed.

Inclusion Criteria:

• Female
• invasive breast cancer patients confirmed by postoperative pathology after surgery for breast lump
• Breast cancer-related chemotherapy and radiotherapy completed
• Young ladies with ages equal 35 or below

Exclusion Criteria:

• Male
• Aged above 35
• Breast Carcinoma in situ
• Women in pregnancy or breastfeeding
• Suffering from other malignant tumors
• Non-compliant patient